$3.89
-0.26-6.27%
In chiusura: -
$3.96
0.071.80%
After hour: 7:57 PM EDT
Comments
Loading...
Stime degli utili, EPS e fatturato
Salarius Pharmaceuticals segnala gli utili su base trimestrale. Questi report sugli utili trimestrali offrono agli investitori uno sguardo ai risultati finanziari di un'azienda per un periodo di 3 mesi. I report sugli utili includono quasi sempre i risultati EPS e i ricavi.
Data degli utili
ago 12
EPS
$-6.750
Ricavi trimestrali
$0.00
Ricavi annuali
(a partire da giu 30)
(a partire da giu 30)
–
Analizza lo storico degli utili di Salarius Pharmaceuticals utilizzando ordinamenti e filtri avanzati.
Get Alert | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
SLRX | Salarius Pharmaceuticals | -$11.40 | — | — | — | $0.00 | — | — | — | 11/13/2025 | |
SLRX | Salarius Pharmaceuticals | -$35.55 | — | -$6.75 | — | $0.00 | — | $0.00 | — | 08/12/2025 | |
SLRX | Salarius Pharmaceuticals | -$49.20 | — | -$15.45 | — | $0.00 | — | $0.00 | — | 05/14/2025 | |
SLRX | Salarius Pharmaceuticals | -$26.40 | — | -$9.90 | — | $0.00 | — | $0.00 | — | 03/24/2025 | |
SLRX | Salarius Pharmaceuticals | -$78.00 | -$36.00 | -$11.40 | 68.33% | $0.00 | — | $0.00 | — | 11/14/2024 | |
SLRX | Salarius Pharmaceuticals | -$171.60 | -$804.00 | -$35.55 | 95.58% | $0.00 | — | $0.00 | — | 08/09/2024 | |
SLRX | Salarius Pharmaceuticals | -$267.60 | -$804.00 | -$49.20 | 93.88% | $0.00 | — | $0.00 | — | 05/13/2024 | |
SLRX | Salarius Pharmaceuticals | -$339.60 | -$121.20 | -$26.40 | 78.22% | $0.00 | — | $0.00 | — | 03/22/2024 | |
SLRX | Salarius Pharmaceuticals | -$296.40 | -$144.00 | -$78.00 | 45.83% | $0.00 | — | $0.00 | — | 11/09/2023 | |
SLRX | Salarius Pharmaceuticals | -$270.00 | -$156.00 | -$171.60 | -10.00% | $0.00 | — | $0.00 | — | 08/10/2023 | |
SLRX | Salarius Pharmaceuticals | -$396.00 | -$310.80 | -$267.60 | 13.90% | $0.00 | — | $0.00 | — | 05/11/2023 | |
SLRX | Salarius Pharmaceuticals | -$272.40 | -$258.00 | -$339.60 | -31.63% | $0.00 | — | $0.00 | — | 03/27/2023 | |
SLRX | Salarius Pharmaceuticals | -$250.80 | -$306.00 | -$296.40 | 3.14% | $0.00 | — | $0.00 | — | 11/10/2022 | |
SLRX | Salarius Pharmaceuticals | -$210.00 | -$300.00 | -$270.00 | 10.00% | $571.39K | — | $0.00 | — | 08/05/2022 | |
SLRX | Salarius Pharmaceuticals | -$180.00 | -$270.00 | -$390.00 | -44.44% | $1.27M | — | $0.00 | — | 05/12/2022 | |
SLRX | Salarius Pharmaceuticals | -$300.00 | -$240.00 | -$270.00 | -12.50% | $1.48M | $430.00K | $0.00 | -100.00% | 03/10/2022 | |
SLRX | Salarius Pharmaceuticals | -$300.00 | -$180.00 | -$240.00 | -33.33% | $1.38M | $1.16M | $0.00 | -100.00% | 11/04/2021 | |
SLRX | Salarius Pharmaceuticals | -$390.00 | -$180.00 | -$210.00 | -16.67% | $1.24M | $1.28M | $571.39K | -55.36% | 08/05/2021 | |
SLRX | Salarius Pharmaceuticals | -$660.00 | -$150.00 | -$180.00 | -20.00% | $1.13M | $1.37M | $1.27M | -7.37% | 05/12/2021 | |
SLRX | Salarius Pharmaceuticals | -$1.32K | -$330.00 | -$300.00 | 9.09% | $1.04M | $1.48M | $1.48M | -0.07% | 03/18/2021 | |
SLRX | Salarius Pharmaceuticals | -$2.19K | -$300.00 | -$300.00 | 0.00% | $874.95K | $1.34M | $1.38M | 2.84% | 11/11/2020 |
Salarius Pharmaceuticals (SLRX) Guadagno per azione
Importo a sorpresa sugli utili trimestrali
| Trimestre fiscale | Data segnalata | EPS effettivo | EPS stimato | Sorpresa% |
|---|---|---|---|---|
| Q3 | 2024-11-14 | $-11.40 | $-36.00 | 68.3 % |
| Q2 | 2024-08-09 | $-35.55 | $-804.00 | 95.6 % |
| Q1 | 2024-05-13 | $-49.20 | $-804.00 | 93.9 % |
| Q4 | 2024-03-22 | $-26.40 | $-121.20 | 78.2 % |
Salarius Pharmaceuticals (SLRX) Entrate
Importo sorpresa sulle entrate trimestrali
| Trimestre fiscale | Data segnalata | Entrate effettive | Entrate stimate | Sorpresa% |
|---|---|---|---|---|
| Q4 | 2022-03-10 | $0 | $430.00K | -100.0 % |
| Q3 | 2021-11-04 | $0 | $1.16M | -100.0 % |
| Q2 | 2021-08-05 | $571.39K | $1.28M | -55.4 % |
| Q1 | 2021-05-12 | $1.27M | $1.37M | -7.37 % |
FAQ
Quando Salarius Pharmaceuticals (NASDAQ:SLRX) riporterà gli utili?
Si prevede che Salarius Pharmaceuticals (SLRX) fornisca risultati il novembre 13, 2025. Gli ultimi risultati sono stati pubblicati il agosto 12, 2025 per il Q2.
Quali sono stati gli ultimi utili per azione (EPS) di Salarius Pharmaceuticals (NASDAQ:SLRX)?
L'EPS effettivo era $-6.75, che mancato la stima di $0.00.
Quali sono state le entrate di Salarius Pharmaceuticals (NASDAQ:SLRX)?
Le entrate effettive sono state $0K, che centrato la stima di $0K.
Sfoglia stime sugli utili, EPS e ricavi su tutte le azioni.